Tune into

Logo Illustration
Logo

'Thinking and acting beyond borders', for the first time, the 2025 WeACT Con will bring an international stream, where experts from different countries will share their knowledge, insights and best practices—telling us what is important to them in their countries' healthcare systems, and where the challenges and opportunity are.

Now in its third year, WeACT Con is Germany’s leading health sustainability conference. This two-day Chiesi-hosted conference, brings together health, environment, and sustainability in a holistic way, incorporating the entire healthcare system.

Grey Textballoon
Purple Textballoon
Logo2

Tune into our livestream as participants explore critical topics and address questions including:

  • How can we further develop our healthcare system collectively?
  • What conflicting goals are there and what areas of action arise from them?
  • Where do workable and environmentally friendly solutions already exist today and how do they work?
  • What is required for taking action together?

We come together every year at WeACT Con to exchange experiences and inspire one another, to hold interdisciplinary dialogues, discuss solutions and implement them together. Let us move forward together with and for healthcare.

 

We look forward to seeing you.

WeACT - We act together.

Testimonies

Tap the particles to explore

You are leaving this website to visit the Chiesi global Facebook page. If you are a UK resident, please visit https://shorturl.at/3MaMa
You are leaving this website to visit the Chiesi global LinkedIn page. If you are a UK resident, please visit https://shorturl.at/dm5bf

You are leaving this website to visit the Chiesi global X page. If you are a resident in the UK or Ireland, please visit https://shorturl.at/dm5bf or https://shorturl.at/vjaQy

You are leaving this website to visit the Chiesi global website. If you are a UK resident, please visit www.chiesi.uk.com.
"I try to get the best medication that is also affordable and within the insurance company’s formulary"
COPD patient from the US